{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:01:34Z","timestamp":1781712094984,"version":"3.54.5"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1007\/bf02826210","type":"journal-article","created":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T09:05:03Z","timestamp":1201770303000},"page":"2-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma"],"prefix":"10.1007","volume":"17","author":[{"given":"R","family":"H\u00e1jek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AW","family":"Butch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,2,1]]},"reference":[{"key":"BF02826210_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF01742306","volume":"34","author":"A \u00d6sterborg","year":"1991","unstructured":"\u00d6sterborg Aet al. Generation of T cell clones binding F(ab\u2032)2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy.Cancer Immunol Immunother 1991;34: 157\u2013162.","journal-title":"Cancer Immunol Immunother"},{"key":"BF02826210_CR2","first-page":"859","volume":"24","author":"RM Steinman","year":"1996","unstructured":"Steinman RM. Dendritic cells and immune-based therapies.Exp Hematol 1996;24: 859\u2013862.","journal-title":"Exp Hematol"},{"key":"BF02826210_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0022-1759(96)00079-8","volume":"196","author":"A Bender","year":"1996","unstructured":"Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.J Immunol Methods 1996;196: 121\u2013135.","journal-title":"J Immunol Methods"},{"key":"BF02826210_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0022-1759(96)00078-6","volume":"196","author":"N Romani","year":"1996","unstructured":"Romani Net al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.J Immunol Methods 1996;196: 137\u2013151.","journal-title":"J Immunol Methods"},{"key":"BF02826210_CR5","first-page":"202","volume-title":"Proceedings of 13th Eur Immunol Meeting","author":"E Maraskovsky","year":"1997","unstructured":"Maraskovsky Eet al. Dramatic increase in the numbers of dendritic cells in the peripheral blood of healthy volunteers treated with Flt3L. In: Wagner Het al. (eds).Proceedings of 13th Eur Immunol Meeting 1997, Amsterdam: Elsevier, p 202."},{"key":"BF02826210_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1126\/science.283.5405.1183","volume":"283","author":"MC Rissoan","year":"1999","unstructured":"Rissoan MCet al. Reciprocal control of T helper cell and dendritic cell differentiation.Science 1999;283: 1183\u20131186.","journal-title":"Science"},{"key":"BF02826210_CR7","first-page":"279","volume":"43","author":"B Barlogie","year":"1998","unstructured":"Barlogie Bet al. Advances in the treatment of multiple myeloma.Adv Int Med 1998;43: 279\u2013320.","journal-title":"Adv Int Med"},{"key":"BF02826210_CR8","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1084\/jem.137.5.1142","volume":"137","author":"RM Steinman","year":"1973","unstructured":"Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice.J Exp Med 1973;137: 1142\u20131161.","journal-title":"J Exp Med"},{"key":"BF02826210_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/00007890-198106000-00005","volume":"31","author":"DNJ Hart","year":"1981","unstructured":"Hart DNJet al. Localization of HLA-ABC and DR antigens in human kidney.Transplantation 1981;31: 428\u2013433.","journal-title":"Transplantation"},{"key":"BF02826210_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00002371-199803000-00007","volume":"21","author":"A Galy","year":"1998","unstructured":"Galy A, Morel F, Hill B, Chen BP. Hematopoietic progenitor cells of lymphocytes and dendritic cells.J Immunother 1998;21: 132\u2013141.","journal-title":"J Immunother"},{"key":"BF02826210_CR11","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1182\/blood.V90.4.1458","volume":"90","author":"C Caux","year":"1997","unstructured":"Caux Cet al. CD34+hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.Blood 1997;90: 1458\u20131470.","journal-title":"Blood"},{"key":"BF02826210_CR12","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1182\/blood.V90.9.3245","volume":"90","author":"DNJ Hart","year":"1997","unstructured":"Hart DNJ. Dendritic cells: unique leukocyte populations which control the primary immune response.Blood 1997;90: 3245\u20133287.","journal-title":"Blood"},{"key":"BF02826210_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0074-7696(08)62188-9","volume":"153","author":"LA Williams","year":"1994","unstructured":"Williams LA, Egner W, Hart DN. Isolation and function of human dendritic cells.Int Rev Cytol 1994;153: 41\u2013103.","journal-title":"Int Rev Cytol"},{"key":"BF02826210_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1084\/jem.182.2.389","volume":"182","author":"F Sallusto","year":"1995","unstructured":"Sallusto F, Cella M, Daniel C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.J Exp Med 1995;182: 389\u2013400.","journal-title":"J Exp Med"},{"key":"BF02826210_CR15","first-page":"799","volume":"4","author":"B Melichar","year":"1998","unstructured":"Melichar B, Savary C, Kudelka AP, Verschraegen C, Kavanagh J. Lineage-negative human leukocyte antigen-DR+cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis.Clin Cancer Res 1998;4: 799\u2013809.","journal-title":"Clin Cancer Res"},{"key":"BF02826210_CR16","first-page":"487","volume":"82","author":"U O'Doherty","year":"1994","unstructured":"O'Doherty Uet al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature.Immunology 1994;82: 487\u2013493.","journal-title":"Immunology"},{"key":"BF02826210_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00007890-199001000-00001","volume":"49","author":"JM Austyn","year":"1990","unstructured":"Austyn JM, Larsen CP. Migration patterns of dendritic leukocytes. Implications for transplantation.Transplantation 1990;49: 1\u20137.","journal-title":"Transplantation"},{"key":"BF02826210_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau J, Steinman RM. Dendritic cells and the control of immunity.Nature 1998;392: 245\u2013252.","journal-title":"Nature"},{"key":"BF02826210_CR19","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.4049\/jimmunol.158.10.4543","volume":"158","author":"SM Barrat-Boyes","year":"1997","unstructured":"Barrat-Boyes SM, Watkins SC, Finn OJ. In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model.J Immunol 1997;158: 4543\u20134547.","journal-title":"J Immunol"},{"key":"BF02826210_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-3083.1988.tb02326.x","volume":"27","author":"S Fossum","year":"1988","unstructured":"Fossum S. Lymph-borne dendritic leucocytes do not recirculate, but enter the lymph node paracortex to become interdigitating cells.Scand J Immunol 1988;27: 97\u2013105.","journal-title":"Scand J Immunol"},{"key":"BF02826210_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1084\/jem.167.2.632","volume":"167","author":"JW Kupiec-Weglinski","year":"1988","unstructured":"Kupiec-Weglinski JW, Austyn JM, Morris PJ. Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and-independent entry to lymphoid tissues.J Exp Med 1988;167: 632\u2013645.","journal-title":"J Exp Med"},{"key":"BF02826210_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1046\/j.1365-2567.1997.00295.x","volume":"91","author":"F Lardon","year":"1997","unstructured":"Lardon Fet al. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1.Immunology 1997;91: 553\u2013559.","journal-title":"Immunology"},{"key":"BF02826210_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1046\/j.1365-2141.1996.5131053.x","volume":"93","author":"K Saraya","year":"1996","unstructured":"Saraya K, Reid CD. Stem cell factor and the regulation of dendritic cell production from CD34+ progenitors in bone marrow and cord blood.Br. J Haematol 1996;93: 258\u2013264.","journal-title":"Br. J Haematol"},{"key":"BF02826210_CR24","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.4049\/jimmunol.154.11.5851","volume":"154","author":"P Szabolcs","year":"1995","unstructured":"Szabolcs P, Moore MA, Young JW. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha.J Immunol 1995;154: 5851\u20135861.","journal-title":"J Immunol"},{"key":"BF02826210_CR25","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1182\/blood.V87.6.2376.bloodjournal8762376","volume":"87","author":"C Caux","year":"1996","unstructured":"Caux Cet al. Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic\/Langerhans cells from cord blood CD34+hema-topietic progenitor cells.Blood 1996;87: 2376\u20132385.","journal-title":"Blood"},{"key":"BF02826210_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1084\/jem.184.2.695","volume":"184","author":"C Caux","year":"1996","unstructured":"Caux Cet al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.J Exp Med 1996;184: 695\u2013706.","journal-title":"J Exp Med"},{"key":"BF02826210_CR27","first-page":"1099","volume":"55","author":"H Bernhard","year":"1995","unstructured":"Bernhard Het al. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.Cancer Res 1995;55: 1099\u20131104.","journal-title":"Cancer Res"},{"key":"BF02826210_CR28","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1046\/j.1365-2141.1997.4283238.x","volume":"99","author":"B Herbst","year":"1997","unstructured":"Herbst Bet al. CD34+ peripheral blood progenitor cell and monocyte derived dendritic cells: a comparative analysis.Brit J Haematol 1997;99: 490\u2013499.","journal-title":"Brit J Haematol"},{"key":"BF02826210_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0022-1759(97)00133-6","volume":"208","author":"M Lopez","year":"1997","unstructured":"Lopez Met al. IL-13 induces CD34+ cells isolated from G-CSF mobilized blood to differentiate in vitro into potent antigen presenting cells.J Immunol Methods 1997;208: 117\u2013129.","journal-title":"J Immunol Methods"},{"key":"BF02826210_CR30","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1182\/blood.V86.7.2699.2699","volume":"86","author":"A Mackensen","year":"1995","unstructured":"Mackensen Aet al. Delineation of the dendritic cell lineage by generating large numbers of Birbeck granulepositive Langerhans cells from human peripheral blood progenitor cells in vitro.Blood 1995;86: 2699\u20132707.","journal-title":"Blood"},{"key":"BF02826210_CR31","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1182\/blood.V87.4.1292.bloodjournal8741292","volume":"87","author":"D Strunk","year":"1996","unstructured":"Strunk D, Rappersberger K, Egger C, Strobl H, Kromer E Generation of human dendritic cells\/Langerhans cells from circulating CD34+ hematopoietic progenitor cells.Blood 1996;87: 1292\u20131302.","journal-title":"Blood"},{"key":"BF02826210_CR32","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1182\/blood.V89.10.3708","volume":"89","author":"DB Fearnley","year":"1997","unstructured":"Fearnley DB, McLellan AD, Mannering SI, Hock BD, Hart DN. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy.Blood 1997;89: 3708\u20133716.","journal-title":"Blood"},{"key":"BF02826210_CR33","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1172\/JCI114525","volume":"85","author":"S Markowicz","year":"1990","unstructured":"Markowicz S, Engleman EG. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro.J Clin Invest 1990;85: 955\u2013961.","journal-title":"J Clin Invest"},{"key":"BF02826210_CR34","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1042\/bst025364s","volume":"25","author":"S Pfeiffer","year":"1997","unstructured":"Pfeiffer S, Apperley JF, Goldschmidt H, Gooding RP. Ex vivo generation and function of dendritic cells in multiple myeloma.Biochem Soc Trans 1997;25: 364.","journal-title":"Biochem Soc Trans"},{"key":"BF02826210_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/eji.1830270213","volume":"27","author":"F Chapuis","year":"1997","unstructured":"Chapuis Fet al. Differentiation of human dendritic cells from monocytes in vitro.Eur J Immunol 1997;27: 431\u2013441.","journal-title":"Eur J Immunol"},{"key":"BF02826210_CR36","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1182\/blood.V87.11.4520.bloodjournal87114520","volume":"87","author":"P Szabolcs","year":"1996","unstructured":"Szabolcs Pet al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate.Blood 1996;87: 4520\u20134530.","journal-title":"Blood"},{"key":"BF02826210_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1084\/jem.180.1.83","volume":"180","author":"N Romani","year":"1994","unstructured":"Romani Net al. Proliferating dendritic cell progenitors in human blood.J Exp Med 1994;180: 83\u201393.","journal-title":"J Exp Med"},{"key":"BF02826210_CR38","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","volume":"179","author":"F Sallusto","year":"1994","unstructured":"Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.J Exp Med 1994;179: 1109\u20131118.","journal-title":"J Exp Med"},{"key":"BF02826210_CR39","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.4049\/jimmunol.157.9.3850","volume":"157","author":"WF Pickl","year":"1996","unstructured":"Pickl WFet al. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+peripheral blood monocytes.J Immunol 1996;157: 3850\u20133859.","journal-title":"J Immunol"},{"key":"BF02826210_CR40","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1084\/jem.170.2.577","volume":"170","author":"JH Jansen","year":"1989","unstructured":"Jansen JHet al. Inhibition of human colony foramation by interleukin 4.J Exp Med 1989;170: 577\u2013582.","journal-title":"J Exp Med"},{"key":"BF02826210_CR41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/360258a0","volume":"360","author":"C Caux","year":"1992","unstructured":"Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.Nature 1992;360: 258\u2013261.","journal-title":"Nature"},{"key":"BF02826210_CR42","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1182\/blood.V82.10.3019.3019","volume":"82","author":"F Santiago-Schwarz","year":"1993","unstructured":"Santiago-Schwarz F, Divaris N, Kay C, Carsons SE. Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development.Blood 1993;82: 3019\u20133028.","journal-title":"Blood"},{"key":"BF02826210_CR43","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1182\/blood.V91.12.4652","volume":"91","author":"BG Chen","year":"1998","unstructured":"Chen BGet al. The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhacing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro.Blood 1998;91: 4652\u20134661.","journal-title":"Blood"},{"issue":"11","key":"BF02826210_CR44","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1182\/blood.V92.11.4238","volume":"92","author":"P Brossart","year":"1998","unstructured":"Brossart Pet al. Generation of human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor.Blood 1998;92, 11: 4238\u20134247.","journal-title":"Blood"},{"key":"BF02826210_CR45","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1073\/pnas.90.8.3735","volume":"90","author":"ANJ McKenzie","year":"1993","unstructured":"McKenzie ANJ, Culpepper JA, de Waal M, Briere R. Interleukin 13, a T cell-derived cytokine that regulates human monocyte and B-cell function.Proc Natl Acad Sci USA 1993;90: 3735\u20133739.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02826210_CR46","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1084\/jem.182.4.1111","volume":"182","author":"JW Young","year":"1995","unstructured":"Young JW, Szabolcs P, Mooe MA. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte\/macrophage colony-stimulating factor and tumor necrosis factor alpha.J Exp Med 1995;182: 1111\u20131119.","journal-title":"J Exp Med"},{"key":"BF02826210_CR47","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.4049\/jimmunol.157.4.1499","volume":"157","author":"H Strobl","year":"1996","unstructured":"Strobl H, Riedl E, Scheinecker C, Bello-Fernandez C, Pickl WF: TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors.J Immunol 1996;157: 1499\u20131507.","journal-title":"J Immunol"},{"key":"BF02826210_CR48","first-page":"159","volume":"88","author":"E Maraskovsky","year":"1996","unstructured":"Maraskovsky Eet al. The effect of Flt3 ligand and\/or c-kit ligand on the generation of dendritic cells from human CD34+ bone marrow.Blood 1996;88 (Suppl.): S159 (abstract).","journal-title":"Blood"},{"key":"BF02826210_CR49","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1046\/j.1365-2141.1998.00693.x","volume":"101","author":"D Soligo","year":"1998","unstructured":"Soligo D,et al. Expansion of dendritic cells derived from human CD34+ cells in static and continuous perfusion cultures.Br J Haematol 1998;101: 352\u2013363.","journal-title":"Br J Haematol"},{"key":"BF02826210_CR50","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.4049\/jimmunol.159.10.4772","volume":"159","author":"K Steinbrink","year":"1997","unstructured":"Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction to tolerance by IL-10-treated dendritic cells.J Immunol 1997;159: 4772\u20134780.","journal-title":"J Immunol"},{"key":"BF02826210_CR51","first-page":"997","volume":"18","author":"Z Ye","year":"1996","unstructured":"Ye Zet al. In vitro expansion and characterization of dendritic cells derived from human bone marrow CD34+ cells.Bone Marrow Transplant 1996;18: 997\u20131008.","journal-title":"Bone Marrow Transplant"},{"key":"BF02826210_CR52","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.184.2.747","volume":"184","author":"M Cella","year":"1996","unstructured":"Cella Met al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin 12 and enhances T cell stimulatory capacity: T-T help via APC activation.J Exp Med 1996,184: 747\u2013785.","journal-title":"J Exp Med"},{"key":"BF02826210_CR53","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1073\/pnas.93.6.2588","volume":"93","author":"LJ Zhou","year":"1996","unstructured":"Zhou LJ, Tedder TF: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.Proc Nat Acad Sci USA 1996;93: 2588\u20132592.","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF02826210_CR54","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1182\/blood.V90.9.3640","volume":"90","author":"A Reddy","year":"1997","unstructured":"Reddy A, Sapp M, Feldman M, Subklewe M, Bhardwaj N. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells.Blood 1997;90: 3640\u20133646.","journal-title":"Blood"},{"key":"BF02826210_CR55","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.178.3.1067","volume":"178","author":"U O'Doherty","year":"1993","unstructured":"O'Doherty Uet al. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium.J Exp Med 1993;178: 1067\u20131076.","journal-title":"J Exp Med"},{"key":"BF02826210_CR56","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4049\/jimmunol.162.1.168","volume":"162","author":"MS Labeur","year":"1999","unstructured":"Labeur MSet al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage.J Immunol 1999;162: 168\u2013175","journal-title":"J Immunol"},{"key":"BF02826210_CR57","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.4049\/jimmunol.161.5.2094","volume":"161","author":"MF Mackey","year":"1998","unstructured":"Mackey MFet al. Dendritic cells require maturation via CD40 to generate protective antitumor immunity.J Immunol 1998;161: 2094\u20132098.","journal-title":"J Immunol"},{"key":"BF02826210_CR58","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1182\/blood.V91.6.1852","volume":"91","author":"K Tarte","year":"1998","unstructured":"Tarte Ket al. Clinical-grade functional dendritic cells from patients with multiple myeloma are not infected with Kaposi's sarcoma-associated herpesvirus.Blood 1998;91: 1852\u20131857.","journal-title":"Blood"},{"key":"BF02826210_CR59","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1182\/blood.V90.9.3482","volume":"90","author":"K Tarte","year":"1997","unstructured":"Tarte Ket al. Generation of virtually pure and potentially proliferating dendritic cells from non-CD34 apheresis cells from patients with multiple myeloma.Blood 1997;90: 3482\u20133495.","journal-title":"Blood"},{"key":"BF02826210_CR60","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1046\/j.1365-3083.1997.d01-441.x","volume":"45","author":"M Makino","year":"1997","unstructured":"Makino M, Baba M. A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells.Scand J Immunol 1997;45: 618\u2013622.","journal-title":"Scand J Immunol"},{"key":"BF02826210_CR61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0011-2240(90)90026-Z","volume":"27","author":"MJ Taylor","year":"1990","unstructured":"Taylor MJ, London NJ, Thirdborough SM, Lake SP, James RF. The cryobiology of rat and human dendritic cells: preservation and destruction of membrane integrity by freezing.Cryobiology 1990;27: 269\u2013278.","journal-title":"Cryobiology"},{"key":"BF02826210_CR62","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/42030","volume":"388","author":"M Cella","year":"1997","unstructured":"Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells.Nature 1997;388: 782\u2013787.","journal-title":"Nature"},{"key":"BF02826210_CR63","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1084\/jem.169.3.1169","volume":"169","author":"N Romani","year":"1989","unstructured":"Romani Net al. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidemal Langerhans cells.J Exp Med 1989;169: 1169\u20131178.","journal-title":"J Exp Med"},{"key":"BF02826210_CR64","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1006\/cimm.1997.1151","volume":"179","author":"S Yang","year":"1997","unstructured":"Yang S, Darrow TL, Vervaert CE, Seigler HF. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow.Cell Immunol 1997;179: 84\u201395.","journal-title":"Cell Immunol"},{"key":"BF02826210_CR65","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1182\/blood.V89.4.1133","volume":"89","author":"A Choudhury","year":"1997","unstructured":"Choudhury Aet al. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia.Blood 1997;89: 1133\u20131142.","journal-title":"Blood"},{"key":"BF02826210_CR66","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1636::AID-IMMU1636>3.0.CO;2-9","volume":"28","author":"SC Knight","year":"1998","unstructured":"Knight SCet al. Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation.Eur J Immunol 1998;28: 1636\u20131644.","journal-title":"Eur J Immunol"},{"key":"BF02826210_CR67","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nm0598-594","volume":"4","author":"L Zitvogel","year":"1998","unstructured":"Zitvogel Let al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.Nat Med 1998;4: 594\u2013600.","journal-title":"Nat Med"},{"key":"BF02826210_CR68","first-page":"579","volume":"90","author":"H Bohlen","year":"1997","unstructured":"Bohlen H, Titzer S, Christensen O, Manzke O. Dendritic cell based idiotype vaccination in multiple myeloma.Blood 1997;90 (Suppl): S579 (abstract).","journal-title":"Blood"},{"key":"BF02826210_CR69","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nm0196-52","volume":"2","author":"FJ Hsu","year":"1996","unstructured":"Hsu FJet al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells.Nature Med 1996;2: 52\u201358.","journal-title":"Nature Med"},{"key":"BF02826210_CR70","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1182\/blood.V93.7.2411","volume":"93","author":"VL Reichardt","year":"1999","unstructured":"Reichardt VLet al. Idiotype vaccination using dendritic autologous peripheral blood stem cell transplantation for multiple myeloma\u2014a feasibility study.Blood 1999;93: 2411\u20132419.","journal-title":"Blood"},{"key":"BF02826210_CR71","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/jlb.59.4.494","volume":"59","author":"MP Everson","year":"1996","unstructured":"Everson MPet al. Dendritic cells from different tissues induce production of different T cell cytokine profiles.J Leukocyte Biology 1996;59: 494\u2013498.","journal-title":"J Leukocyte Biology"},{"key":"BF02826210_CR72","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1084\/jem.180.4.1263","volume":"180","author":"C Caux","year":"1994","unstructured":"Caux Cet al. Activation of human dendritic cells through CD40 cross-linking.J Exp Med 1994;180: 1263\u20131272","journal-title":"J Exp Med"},{"key":"BF02826210_CR73","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1084\/jem.186.12.2075","volume":"186","author":"BR Wong","year":"1997","unstructured":"Wong BRet al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.J Exp Med 1997;186: 2075\u20132080.","journal-title":"J Exp Med"},{"key":"BF02826210_CR74","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1084\/jem.185.9.1595","volume":"185","author":"R Godiska","year":"1997","unstructured":"Godiska Ret al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells.J Exp Med 1997;185: 1595\u20131604.","journal-title":"J Exp Med"},{"key":"BF02826210_CR75","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/eji.1830260323","volume":"26","author":"C Heufler","year":"1996","unstructured":"Heufler Cet al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells.Eur J Immunol 1996;26: 659\u2013668.","journal-title":"Eur J Immunol"},{"key":"BF02826210_CR76","first-page":"111","volume":"92","author":"M Arpinati","year":"1998","unstructured":"Arpinati M, Loken M, Anasetti C. G-CSF mobilizes 2-dendritic cells rather than type 1-dendritic cells.Blood 1998;92 (Suppl): S111 (abstract).","journal-title":"Blood"},{"key":"BF02826210_CR77","first-page":"444","volume":"92","author":"JS Haug","year":"1998","unstructured":"Haug JSet al.: Mobilization of CD80+ dendritic cells into the peripheral circulation by GM-CSF but not CSF.Blood 1998;92 (Suppl.): S444 (abstract).","journal-title":"Blood"},{"key":"BF02826210_CR78","first-page":"85","volume":"23","author":"R H\u00e1jek","year":"1996","unstructured":"H\u00e1jek R, Adam Z, V\u00e1\u015dov\u00e1 I, Kr\u00e1l Z. Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantation.Acta Med Austriaca 1996;23: 85\u201391.","journal-title":"Acta Med Austriaca"},{"key":"BF02826210_CR79","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1046\/j.1365-2141.1998.00633.x","volume":"100","author":"S Dabadghao","year":"1998","unstructured":"Dabadghao Set al. Anti-idiotypic T-cell activation in multiple myeloma induced by M-component fragments presented by dendritic cells.Br J Haematol 1998;100: 647\u2013654.","journal-title":"Br J Haematol"},{"key":"BF02826210_CR80","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1084\/jem.178.3.1023","volume":"178","author":"D Billadeau","year":"1993","unstructured":"Billadeau D, Ahmann G, Greipp P, Van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.J Exp Med 1993;178: 1023\u20131031.","journal-title":"J Exp Med"},{"key":"BF02826210_CR81","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0140-6736(95)90757-2","volume":"345","author":"LW Kwak","year":"1995","unstructured":"Kwak LWet al. Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor.Lancet 1995;345: 1016\u20131020.","journal-title":"Lancet"},{"key":"BF02826210_CR82","first-page":"579","volume":"90","author":"LW Kwak","year":"1997","unstructured":"Kwak LWet al. T-cell responses elicited by immunization of multiple myeloma patients with idiotypic M-protein plus GM-CSF in remission after autologous transplantation.Blood 199790 (Suppl): S579 (abstract).","journal-title":"Blood"},{"key":"BF02826210_CR83","first-page":"1","volume":"8","author":"S Battaglio","year":"1996","unstructured":"Battaglio S, Napoli P, Beggiato E, Borrione P. Development of vaccines against autologous tumor-derived idiotype in human myeloma: rationale and preparation.Minerva Biotec 1996;8: 1\u20138.","journal-title":"Minerva Biotec"},{"key":"BF02826210_CR84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/10428199509051704","volume":"17","author":"M Massaia","year":"1995","unstructured":"Massaia M, Pileri A. T cells in multiple myeloma: is this a reliable population to count on as antitumor effector cells?Leuk Lymphoma 1995;17: 63\u201370.","journal-title":"Leuk Lymphoma"},{"key":"BF02826210_CR85","first-page":"S38","volume":"36","author":"FK Stevenson","year":"1999","unstructured":"Stevenson FK, Link ChJ, Traynor A, Yu H, Corr M. DNA vaccination against multiple myeloma.Semin Hematol 1999;36 (Suppl): S38-S42.","journal-title":"Semin Hematol"},{"key":"BF02826210_CR86","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1046\/j.1365-2141.1996.419959.x","volume":"92","author":"S Bergenbrant","year":"1996","unstructured":"Bergenbrant Set al. Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients.Br J Haematol 1996;92: 840\u2013846.","journal-title":"Br J Haematol"},{"key":"BF02826210_CR87","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1182\/blood.V91.7.2459","volume":"91","author":"A \u00d6sterborg","year":"1998","unstructured":"\u00d6sterborg Aet al. Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses.Blood 1998;91: 2459\u20132466.","journal-title":"Blood"},{"key":"BF02826210_CR88","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1046\/j.1365-2141.1997.3123128.x","volume":"98","author":"S Pfeiffer","year":"1997","unstructured":"Pfeiffer Set al. Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors.Br J Haematol 1997;98: 973\u2013982.","journal-title":"Br J Haematol"},{"key":"BF02826210_CR89","first-page":"2709","volume":"4","author":"D Choi","year":"1998","unstructured":"Choi Det al. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.Clin Cancer Res 1998;4: 2709\u20132716.","journal-title":"Clin Cancer Res"},{"key":"BF02826210_CR90","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood.V92.1.108.413k11_108_117","volume":"92","author":"HS Lim","year":"1998","unstructured":"Lim HS, Bailey-Wood R. Id-pulsed dendritic cell vaccination in multiple myeloma.Blood 1998;92 (Suppl): S108 (abstract).","journal-title":"Blood"},{"key":"BF02826210_CR91","first-page":"957","volume":"4","author":"YJ Wen","year":"1998","unstructured":"Wen YJ, Ling M, Bailey-Wood R, Lim SH. Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma.Clin Cancer Res 1998;4: 957\u2013962.","journal-title":"Clin Cancer Res"},{"key":"BF02826210_CR92","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood.V92.1.108.413k11_108_117","volume":"92","author":"M MacKenzie","year":"1998","unstructured":"MacKenzie M, Strang G, Peshwa M, Sopapan J, Valone F. Phase I\/II trial of immunotherapy with idiotype-loaded autologous dendritic cells (APC8020) for refractory multiple myeloma.Blood 1998;92 (Suppl): S108 (abstract).","journal-title":"Blood"},{"key":"BF02826210_CR93","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00001622-199703000-00006","volume":"9","author":"HJ Kolb","year":"1997","unstructured":"Kolb HJ, Holler E. Adoptive immunotherapy with donor lymphocyte transfusions.Curr Opin Oncol 1997;9: 139\u2013145.","journal-title":"Curr Opin Oncol"},{"key":"BF02826210_CR94","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1182\/blood.V90.10.4206","volume":"90","author":"HM Lokhorst","year":"1997","unstructured":"Lokhorst HMet al. Donor leukocyte infusions are effective in relapsed multiple myelomas after allogeneic bone marrow transplantation.Blood 1997;90: 4206\u20134211.","journal-title":"Blood"},{"key":"BF02826210_CR95","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1182\/blood.V87.3.1196.bloodjournal8731196","volume":"87","author":"G Tricot","year":"1996","unstructured":"Tricot Get al. Graft-versus-myeloma effect: proof of principle.Blood 1996;87: 1196\u20131198.","journal-title":"Blood"},{"key":"BF02826210_CR96","first-page":"283","volume":"16","author":"MC Benyunes","year":"1995","unstructured":"Benyunes MCet al. Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial.Bone Marrow Transplant 1995;16: 283\u2013288.","journal-title":"Bone Marrow Transplant"},{"key":"BF02826210_CR97","first-page":"351","volume":"17","author":"C Massumoto","year":"1996","unstructured":"Massumoto Cet al. Close stimulation of acute graftversus host disease by interleukin-2 administered after autologous bone marrow transplantation for hematological malignancies.Bone Marrow Transplant 1996;17: 351\u2013356.","journal-title":"Bone Marrow Transplant"},{"key":"BF02826210_CR98","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1200\/JCO.1997.15.2.667","volume":"15","author":"S Giralt","year":"1997","unstructured":"Giralt Set al. Phase I trials of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.J Clin Oncol 1997;15: 667\u2013673.","journal-title":"J Clin Oncol"},{"key":"BF02826210_CR99","first-page":"691","volume":"15","author":"F Beaujeaun","year":"1995","unstructured":"Beaujeaun Fet al. Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin-2 patients with acute lymphoblastic leukemia.Bone Marrow Transplant 1995;15: 691\u2013696.","journal-title":"Bone Marrow Transplant"},{"key":"BF02826210_CR100","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1089\/scd.1.1997.6.457","volume":"6","author":"KR Meehan","year":"1997","unstructured":"Meehan KRet al. A pilot study evaluating interleukin-2-activated hematopoietic stem cell transplantation for hematologic malignancies.J Hematother 1997;6: 457\u2013464.","journal-title":"J Hematother"},{"key":"BF02826210_CR101","first-page":"63","volume":"26","author":"M Rosenzwajg","year":"1998","unstructured":"Rosenzwajg M, Camus S, Guigon M, Gluckman JC. The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells.Exp Hematol 1998;26: 63\u201372","journal-title":"Exp Hematol"},{"key":"BF02826210_CR102","first-page":"1465","volume":"23","author":"S Siena","year":"1995","unstructured":"Siena Set al. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.Exp Hematol 1995;23: 1465\u20131473.","journal-title":"Exp Hematol"},{"key":"BF02826210_CR103","first-page":"4187","volume":"92","author":"G Cull","year":"1998","unstructured":"Cull G, Durrant L, Haynes A, Russell N. Generation of idiotype-specific immune responses following vaccination with autologous paraprotein pulsed dendritic cells in myeloma.Blood 1998;92 (Suppl): S4187 (abstract).","journal-title":"Blood"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02826210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02826210\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02826210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02826210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T02:19:26Z","timestamp":1702606766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02826210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["BF02826210"],"URL":"https:\/\/doi.org\/10.1007\/bf02826210","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]},"assertion":[{"value":"1 February 2000","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}